Global lmmunohistochemistry (IHC) Reagents and Kits Market – Industry Trends and Forecast to 2029

1. Global lmmunohistochemistry (IHC) Reagents and Kits Market – Industry Trends and Forecast to 2029 lmmunohistochemistry (IHC) Reagents and Kits Market Analysis and Size The immunohistochemistry (IHC) sector will experience tremendous growth due to the rise in the prevalence of chronic diseases and the increase in drug research activities. In addition to this, the enormous need for diagnosing cancer, heart conditions, and other viral illnesses like Swine Flu, Bird Flu, and COVID has revealed the importance of immunohistochemistry in the healthcare industry, unleashing market trends. Additionally, over the course of the assessment period, the growth of the immunohistochemistry (IHC) business will be influenced by regulatory approvals as well as the introduction of new products. Data Bridge Market Research analyses that the immunohistochemistry (IHC) reagents and kits market which was USD 2.3 billion in 2021, would rocket up to USD 4.18 billion by 2029, and is expected to undergo a CAGR of 7.75% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework. https://www.databridgemarketresearch.com/reports/global-immunohistochemistry-ihc-reagents-and-kits-market

2. Report Description https://www.databridgemarketresearch.com/reports/global-immunohistochemistry-ihc-reagents-and-kits-market Market Definition Immunohistochemistry, also known as IHC, is a method that effectively utilises monoclonal and polyclonal antibodies to identify certain antigens in tissues, consequently identifying various diseases in individuals. The IHC approach is broken down into two phases: analysing and quantifying the resulting gene expression and first, preparation of the slides and stages involved in the reaction. Additionally, immunohistochemistry is essential for scientific research projects and the interpretation of differential diagnoses that cannot be made with the aid of eosin and hematoxylin in traditional analysis. In pathology, it is mostly used in the fields of hematopathology, oncologic pathology, and neuropathology. Additionally, immunohistochemistry combines histology and immunology. lmmunohistochemistry (IHC) Reagents and Kits Market Dynamics Drivers Increasing incidence of chronic diseases and technological advancements in IHC The growing incidence and prevalence of cancer, technical progressions in IHC, and the availability of reimbursement for IHC tests are the major factors driving the growth of this market. Rise in chronic diseases The market's expansion is mostly fuelled by the ageing population's increased prevalence of chronic and infectious diseases, the development of IHC technology, and the availability of IHC test reimbursements.

3. Market Overview • Recent Development • In March 2020, Visiopharm and Agilent Technologies Inc., two biotechnology companies, announced a collaboration to market their histology tests for cancer patient testing and pathology and to develop a better solution for the cancer diagnosis market. • In June 2019, PHC Holding bought Thermo Fisher Scientific, Inc.'s Anatomical Pathology division, which sells IHC products. • In August 2019, The one and only vitro diagnostic ROS1 IHC assay was introduced by Roche with the VENTANA ROS1 (SP384) Rabbit Monoclonal Primary Antibody. • Product • Antibodies • Equipment • Slide Staining Systems • Tissue Microarrays • Tissue Processing Systems • Slide Scanners • Reagents • Chromogenic Substrates • Historical Stains

4. Key Players • Some of the major players operating in the immunohistochemistry (IHC) reagents and kits market are: • F. Hoffman-La Roche AG (Switzerland) • Danaher (U.S.) • Agilent Technologies, Inc. (U.S.) • Merck KGaA (Germany) • Bio-Rad Laboratories, Inc. (U.S.) • Bio-Techne Corporation (U.S.) • Abcam plc (U.K.) • BD (U.S.) • PerkinElmer, Inc. (U.S.) • Takara Bio, Inc. (Japan) • Thermo Fisher Scientific, Inc. (U.S.) • PHC Holdings Corporation (Japan) • Cell Signaling Technology, Inc. (U.S.) • Bio SB, Inc. (U.S.) • MiltenyiBiotec (Germany)

5. About Data Bridge Market Research An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth  the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Read Continue : http://databridgemarketresearch.com/about-us/ Contact Us : SopanGedam Sopan.gedam@databridgemarketresearch.com